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Ensuring that patients do not overstay the expected 
Length of Stay (LOS) in the hospital is an important 
indicator of the quality of care and helps to reduce the cost 
of healthcare. This study identifies the predictors of 
Extended Length of Hospital Stay (ELOHS) for surgical 
and medical patients to include LOS (>20 days), Age (> 40 
years), Hour to Surgery (HTS) – within 4 hours of 
admission, zero and one Rapid Response Team (RRT) 
calls, Average Operating Room Time (AORT) of 0 – 120 
minutes and one Theatre Session (TS). Apart from the “ear, 
nose, mouth & throat”, “kidney and urinary tract”, 
“circulatory system”, “nervous system” and “digestive 
system” Major Diagnostic Categories (MDCs), other 
considered MDCs have significant differences in the 
Classification of Hospital Acquired Diagnoses (CHADx) 
rate for ELOHS and Normal Length of Hospital Stay 
(NLOHS) patients. It is expected that the early 
consideration of ELOHS predictors will be vital in 
improving patients’ outcomes in the hospital 
1. Introduction  
Hospital admission is very important for saving lives 
through enhanced care for the sick with facilities that will 
ordinarily not be available in health centres. However, 
when patients overstay in the hospital, it starts to constitute 
problems for them, the hospital, and the wider economy 
due to the mounting costs [1-4]. Patients can develop other 
comorbidities and complications due to the numerous 
nosocomial infections [5] that have been shown to hamper 
the quality-of-life during and after hospital admissions [6]. 
Extended Length of Hospital Stay (ELOHS), which is 
described as patients overstaying the high trim point 
(3*average LOS) for a particular Diagnosis Related Group 
(DRG), has also contributed negatively to the hospital 
image because it has been used as one of the quality 
indicators of good hospital care [7]. Imperatively, affecting 
hospitals’ insurance reimbursement because of the 
penalties imposed on them for poor patient care [8]. 
Numerous studies have looked at ELOHS for different 
disease conditions to identify the factors responsible for 
patients overstaying the time they are expected to stay in 
hospital. Passias et al. [9] studied the influencing factors of 
ELOHS for cervical spondylotic myelopathy and showed 
that age, diabetes, posterior surgical approach, and 
operative time are among the contributors. ELOHS 
amongst patients that underwent hindfoot arthrodesis 
procedure were identified to include diabetes neuropathy, 
external fixation and infections, and external factors such 
as possession of health insurance policy [10]. Cheng et al. 
[29] attributed ELOHS to older age, cognitive impairment, 
higher number of medical conditions requiring medication, 
and violence during hospital stay for psychiatric patients 
whereas Dial et al. [30] identified those older than 65 years, 
marital status, private health insurance, African American 
race, removal of iliac crest autograph used for spinal fusion 
as some of the psychosocial factors contributing to 
ELOHS. Marfil-Garza et al. [23] showed that younger age, 
male gender, a lower physician-to-patient ratio, emergency 
and weekend admissions, surgery, the number of 
comorbidities, residence outside the city and lower 
socioeconomic status are influencers of ELOHS. 
ELOHS has been linked to increased hospitalization 
and decreased survival rate after carotid endarterectomy 
while being influenced by risk factors such as history of 
congestive heart failure, chronic obstructive pulmonary 
disease, total time in operating room, number of hospital 
visits, Intensive Care Unit (ICU) transfers, and placement 
of Foley catheter over [11]. Patients with deep sternal 
wound infection have been identified to overstay in 
hospitals due to factors that include diabetes, obesity, heart 
failure, renal impairment, and complex surgical procedures 
[12]. Patients with unruptured adult cerebral aneurysms 
have risk factors of ELOHS that comprise demographics 
factors, preadmission comorbidities, choice of procedures, 
and inpatient complications [3]. For the elderly patients in 
the acute care hospital context, ELOHS is influenced by 
tube feeding, consumption of five or more medications, 
non-independent status, urinary tract infection, pneumonia, 
congestive heart failure, and hypoalbuminemia [13]. 
Despite the myriads of studies and the findings, 
ELOHS has not been considered holistically to allow 
hospitals to tailor down their focus on patients of specific 
characteristics to improve care and facilitate recovery. 
Even though many studies have relied on the ELOHS that 






varied from 1 – 9 days for different DRGs [9, 14-16], they 
have produced DRG specific risk factors that failed to 
consider a wide range of hospital-specific predictors. 
Looking at the fact that complication rates in hospitals are 
always higher for patients that overstayed than those with 
a normal length of stay [31], it becomes necessary to 
understand how the influencers of ELOHS impact 
Hospital-acquired complications (HACs). Since the use of 
Classification of Hospital Acquired Diagnoses (CHADx) 
to measure HAC for patients [32] makes it easier to narrow 
the hospital complications by identifying, counting, and 
observing the numerous adverse events on patients during 
admission to improve their safety [33], it suffices to 
understand how ELOHS, and the factors studied in this 
study can influence CHADx. Because the importance of 
having a bigger picture of patients’ status in managing 
ELOHS cannot be overemphasized and knowing the 
hospital-specific factors can help caregiving ab initio, this 
study intends to answer the following research questions. 
- What are the psychosocial and hospital-specific 
predictors of ELOHS for surgical and medical patients 
undergoing various treatments in the hospital? 
- What is the relationship between these risk factors? 
- How does ELOHS impact the CHADx for patients of 
different age groups? 
To answer these questions involves analyzing available 
medical records, categorizing the hospital and psychosocial 
traits of the patients, and ensuring that only hospital-based 
factors relating to patient’s admission are considered. This 
will help to give administrators an indication of the outlier 
conditions that need better control in patients’ management 
to forestall their contributions to ELOHS.  
This study, therefore, aims to use the medical records 
of patients from an academic hospital to determine the 
hospital and psychosocial predictors of ELOHS for 
surgical and medical patients. The major contribution of 
this study is separately identifying the risk factors of 
ELOHS for surgical and medical patients in a hospital 
context where patients of numerous DRGs are treated at the 
same time. By relying on hospital-specific factors, which 
include VMO specialty, admission category, distance to 
hospital, socioeconomic status, etc., this study can bring a 
new dimension to the understanding of ELOHS predictors, 
hence giving room for prioritizing patients’ management 
on admission. This will help to minimize overstaying in 
hospitals for the patients that are most vulnerable to 
ELOHS. 
2. Methods 
This study relied on de-identified data from an 
academic hospital situated in Melbourne Australia for the 
retrospective analysis of ELOHS for surgical and medical 
patients admitted between 10/2015 – 12/2020. Surgical 
patients were identified as those who had time in the 
operating theatre for any procedure whereas medical 
patients were not sent to the operating theatre. The patients 
with ELOHS are those identified as staying more than the 
high trim point (3 * average LOS) for a Diagnosis Related 
Group (DRG) whereas those with Normal Length of 
Hospital Stay (NLOHS) did not overstay the high trim 
point of their DRG despite the LOS in hospital. 
The features used for the analysis include Visiting 
Medical Office (VMO) Specialty, Patient Age, Patient 
Gender, Admission Category (ADC), Patient LOS, Hours 
to Surgery (HTS), MDC Details, Patient Care Class, 
Average Operating Room Time (AORT) in minutes, 
Charlson Score (CS), Unplanned readmission (UPR), 
CHADx, Hospital-Acquired Complications (HACs), 
Return to Operating Room (ROR), ICU transfer, 
Transfusion (TRAF), Theatre Sessions (TS), Rapid 
Respond Team (RRT) calls, Day of Admission Surgery 
Patients (DOP) and Postcode. The postcode was used in 
conjunction with the socio-economic indexes for areas 
(SEIFA) from the Australian Bureau of Statistics (ABS) 
[17] to determine the Socioeconomic Status (SES) of the 
patients by ranking them as low (1-4 decile), middle (5-7 
decile) and high (8-10 decile). The patient's distance to the 
hospital (DTH) was determined by using the Global 
Positioning System (GPS) distance calculation that relies 
on the longitudes, and latitudes of the patient postcode and 
the hospital postcode. 
2.1. Statistical Analysis 
The study relies on descriptive statistics, Pearson Chi-
squared and correlation coefficient analysis, and 
multivariate regression analysis for establishing the 
frequencies of occurrence and interrelationship between 
the features for ELOHS and NLOHS of patients. The Odds 
Ratio (OR), which depicts the likelihood of ELOHS is 
determined by using the dichotomous yes (ELOHS) or no 
(NLOHS) classification of patients' episodes from the 
retrospective records using the high trim points of the 
DRGs as the boundaries. Thus, patients who overstayed the 
high trim points are classified as yes whereas those who did 
not overstay are classified as no. To establish the statistical 
significance of the rate of hospital complications on 
admission, the Pearson Chi-squared analysis was used to 
determine the statistical significance of the CHADx 
between the ELOHS and NLOHS patients. The rate of 
patients’ CHADx for various age groups namely, <18 
years, 18 – 40 years, 40 – 65 years, and ≥65 years was used 
for establishing the statistical significance difference at a 
95% confidence interval. The correlation coefficient is 
used to establish the influence the studied features have on 
each other to understand how the changes in each one for 
both ELOHS and NLOHS influence others. 
3. Results  
3.1 Descriptive Statistics of Predictors 
The analysis is done on 21926 surgical and 11826 
medical patients records, which has 46% male and 54% 
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female for the surgical patients, and 36% male and 
64% female medical patients. The mean ages of the 
surgical patients are male – 64.53±20.46 years and female 
– 61.57±21.71 years whereas medical patients have the 
mean ages of male and female as 69.36±23.86 and 
66.05±25.37, respectively. The AORT and LOS of 
surgical patients are – AORT: male – 65.12±62.10 mins, 
female – 65.63±58.10 mins; LOS male – 5.91± 10.74 
days, female – 6.28±9.98 days. The LOS of medical 
patients are – male 6.22±8.32 days and female 6.99±8.72 
days while the ELOHS rate is 12.41% and 9.94%, 
respectively for surgical and medical patients.  
The various MDCs admitted between 0 – 1.79% and 
0.14 – 1.36% of surgical and medical patients 
respectively, who overstayed their LOS in the hospital. 
The VMO specialties admissions for patients with 
NLOHS are 0.26 – 13.17% (±3.22%) for surgical patients 
and 0.69 – 13.17% (±3.11%) for medical patients. The 
summary of some descriptive statistics of some 
parameters used for the analysis is shown in Table 1 
whereas the high trim points for the MDCs and the 
various DRGs are shown in Table 2. Please note that 
some psychosocial and hospital parameters such as VMO 
specialties, SES of patients, and DTH are not included in 




Table 1: Descriptive statistics (count, %) of some of the features used for predicting the ELOHS and NLOHS for surgical and medical patients 
Parameters NLOHS ELOHS NLOHS ELOHS 
Surgical Patients Medical Patients 
Population 21926 11826 
ELOHS rate 12.41% 9.94% 
Patient Age 
under_18 933(98.11%) 18(1.89%) 548(96.31%) 21(3.69%) 
18-40 2429(94.55%) 140(5.45%) 1698(97.31%) 47(2.69%) 
40-65 5663(91.38%) 534(8.62%) 1691(93.68%) 114(6.32%) 
65 and over 10180(83.38%) 2029(16.62%) 6713(87.1%) 994(12.9%) 
Patient Gender 
Female 10179(86.48%) 1591(13.52%) 6733(89.2%) 815(10.8%) 
Male 9026(88.87%) 1130(11.13%) 3917(91.56%) 361(8.44%) 
Patient Length of Stay (LOS) 
≤5days 15600(99.43%) 90(0.57%) 7828(99.92%) 6(0.08%) 
6-10days 2319(71.22%) 937(28.78%) 1969(94.53%) 114(5.47%) 
11-20days 942(51.96%) 871(48.04%) 667(53.83%) 572(46.17%) 
>20days 344(29.48%) 823(70.52%) 186(27.76%) 484(72.24%) 
Major Diagnostic Category (MDC) 
BLOOD, BLOOD FORM ORGANS, 
IMMUNOLOG 
158(84.49%) 29(15.51%) 240(90.91%) 24(9.09%) 
CIRCULATORY SYSTEM 2809(86.01%) 457(13.99%) 1343(89.95%) 150(10.05%) 
DIGESTIVE SYSTEM 2823(85.18%) 491(14.82%) 1308(90.02%) 145(9.98%) 
EAR, NOSE, MOUTH & THROAT 891(93.89%) 58(6.11%) 551(86.09%) 89(13.91%) 
ENDOCRINE, NUTRITIONAL & 
METABOLIC 
624(91.9%) 55(8.1%) 192(89.3%) 23(10.7%) 
HEPATOBILIARY SYSTEM & PANCREAS 712(85.58%) 120(14.42%) 150(93.75%) 10(6.25%) 
INFECTIOUS & PARASITIC DISEASES 140(74.07%) 49(25.93%) 430(89.03%) 53(10.97%) 
INJURY, POISON & TOXIC EFFECT DRUGS 313(82.37%) 67(17.63%) 279(90%) 31(10%) 
KIDNEY & URINARY TRACT 1303(86.64%) 201(13.36%) 637(89.47%) 75(10.53%) 
MUSCULOSKELETAL SYS & CONN 
TISSUE 
3809(88.56%) 492(11.44%) 914(88.65%) 117(11.35%) 
NEOPLASTIC DISORDERS 108(70.13%) 46(29.87%) 160(88.89%) 20(11.11%) 
NERVOUS SYSTEM 539(83.96%) 103(16.04%) 928(86.97%) 139(13.03%) 
PREGNANCY, CHILDBIRTH & 
PUERPERIUM 
782(98.36%) 13(1.64%) 1161(99.23%) 9(0.77%) 
RESPIRATORY SYSTEM 639(90.25%) 69(9.75%) 1386(94.41%) 82(5.59%) 
SKIN, SUBCUTANEOUS TISSUE & BREAST 1422(84.14%) 268(15.86%) 423(91.96%) 37(8.04%) 
Classification of Hospital-acquired Diagnosis (CHADx) 
No 16119(91.28%) 1540(8.72%) 8687(91.98%) 757(8.02%) 
Yes 3086(72.32%) 1181(27.68%) 1963(82.41%) 419(17.59%) 
Charlson Score (CS) 
0-1 6901(93.19%) 504(6.81%) 3323(95.87%) 143(4.13%) 
2-4 9966(87.1%) 1476(12.9%) 5021(88.18%) 673(11.82%) 
5-8 1992(75.66%) 641(24.34%) 1956(86.51%) 305(13.49%) 
>8 346(77.58%) 100(22.42%) 350(86.42%) 55(13.58%) 
Average Operating Theatre Time -AOTT (min) 
0-60 11159(86.25%) 1779(13.75%) 
  
60-120 5210(89.95%) 582(10.05%) 
  
>120 2836(88.74%) 360(11.26%)     
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VMO (Visiting Medical Officer) Specialty 
Cardiology 2028(87.79%) 282(12.21%) 842(91.32%) 80(8.68%) 
Colorectal Surgery 1187(86.64%) 183(13.36%) 247(92.86%) 19(7.14%) 
Endocrinology 58(53.21%) 51(46.79%) 58(53.21%) 51(46.79%) 
Gastroenterology 980(85.07%) 172(14.93%) 980(85.07%) 172(14.93%) 
Gynecology 394(92.49%) 32(7.51%) 394(92.49%) 32(7.51%) 
Hematology 129(65.82%) 67(34.18%) 129(65.82%) 67(34.18%) 
Medical Oncology 251(69.53%) 110(30.47%) 251(69.53%) 110(30.47%) 
Nephrology 137(45.67%) 163(54.33%) 137(45.67%) 163(54.33%) 
Neurology 83(51.88%) 77(48.13%) 83(51.88%) 77(48.13%) 
Neurosurgery 1085(95.51%) 51(4.49%) 1085(95.51%) 51(4.49%) 
Obstetrics & Gynae 938(98.01%) 19(1.99%) 938(98.01%) 19(1.99%) 
Orthopedic Surgery 2888(90.59%) 300(9.41%) 2888(90.59%) 300(9.41%) 
Distant to Hospital (DTH) 
>20km 5232(89.53%) 612(10.47%) 1121(88.9%) 140(11.1%) 
5-10km 4686(87.36%) 678(12.64%) 3002(89.96%) 335(10.04%) 
0-5km 5440(85.97%) 888(14.03%) 4467(91%) 442(9%) 
10-20km 3847(87.63%) 543(12.37%) 2060(88.83%) 259(11.17%) 
Socioeconomic status (SES) 
High 15230(87.31%) 2213(12.69%) 9893(90.35%) 1057(9.65%) 
Low 1802(87.73%) 252(12.27%) 313(86.7%) 48(13.3%) 
Middle 2163(89.49%) 254(10.51%) 444(86.21%) 71(13.79%) 
 
 
Table 2: The Diagnosis Related Groups (DRGs) high trim point – 3 * average LOS (Q3) of the Length of Stay (LOS) of the various Major 
Diagnostic Categories (MDCs) and examples of DRG considered in the study. 
MDC DRG description DRG (Q3) in (days) 
Mean ± std  Min - Max  
Nervous System 
cranial and peripheral nerve disorders; degenerative nervous system 
disorders; delirium; dementia and other chronic disturbances of 
cerebral function; headache; nervous system neoplasm; nontraumatic 
stupor and coma; seizure. stroke and other cerebrovascular disorders 
20.25±12.03 6 - 58 
Endocrine, Nutritional & 
Metabolic 
metabolic disorders; endocrine disorders; diabetes; severe nutritional 
disturbance. 
19.26±9.41 5 - 60 
Kidney & Urinary Tract 
renal failure; kidney and urinary tract signs; urinary stones and 
obstruction. 
15.93±10.48 5 - 56 
Male Reproductive 
System 
inflammation and malignity of the male reproductive system; benign 
prostatic hypertrophy. 
14.2±8.02 4 - 31 
Female Reproductive 
System 
menstrual and other female reproductive system disorders; malignancy, 
female reproductive system; infections,  
12.15±6.29 4 - 33 
Pregnancy, Childbirth & 
Puerperium 
vaginal delivery; antenatal and other obstetric admission; vaginal 
delivery single uncomplicated; postpartum and post abortion. 
11.81±1.6 3 - 18 
Newborns & Other 
Neonates 
neonate, admission wt. 2000-2499 g  20.89±14.18 7 - 60 
 Blood, Blood Form 
Organs, Immunology 
reticuloendothelial and immunity disorders; red blood cell disorders; 
coagulation disorders 
12.98±6.75 7 - 31 
Neoplastic Disorders lymphoma and non-acute leukemia; neoplastic disorders. 16.64±11.5 13 - 60 
Infectious & Parasitic 
Diseases 
viral illness; septicemia; postoperative and post-traumatic infections; 
fever of unknown origin; infectious and parasitic diseases. 
19.39±12.22 9 - 60 
 Mental Diseases & 
Disorders 
anxiety disorders; personality disorders and acute reactions; major 
affective disorders age >69; 
29.65±18.88 16 - 60 
Eye Diseases & 
Disorders 
retinal procedures; hyphemia and medically managed trauma to the 
eye; neurological and vascular disorders of the eye; acute and major 
eye infections. 
13.95±6.12 4 - 32 
 Alcohol/Drug Use 
Disorders 
drug intoxication and withdrawal 31.11±14.55 18 - 56 
Injury, Poison & Toxic 
Effect Drugs 
 poisoning and toxic effect diagnosis; allergic reactions; injuries. 15.49±8.46 7 - 46 
Factors Influencing 
Health Status 
surgical follow-up and medical care. 14.63±6.06 6 - 41 
Ear, Nose, Mouth & 
Throat 
tonsillectomy and/or adenoidectomy; otitis media and URI; nasal 
trauma and deformity; epistaxis; disequilibrium. 
9.49±2.89 3 - 13 
Respiratory System 
whooping cough and acute bronchiolitis; respiratory system diagnosis; 
respiratory neoplasms; respiratory infections/inflammations; pulmonary 
embolism; chronic obstructive airways disease; bronchoscopy; 
21.66±9.13 4 - 47 
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pneumothorax; major chest trauma; interstitial lung disease; bronchitis 
and asthma. 
Circulatory System 
venous thrombosis; valvular disorders; unstable angina; syncope and 
collapse; peripheral vascular disorders; heart failure and shock; chest 
pain; arrhythmia, cardiac arrest, and conduction disorders; 
hypertension; heart failure and shock; arrhythmia, cardiac arrest, and 
conduction disorders. 
15.56±10.34 4 - 60 
Digestive System 
esophagitis and gastroenteritis; GI obstruction; digestive malignancy; 
complex gastroscopy; abdominal pain or mesenteric adenitis; 
inflammatory bowel disease; anal and stomal; abdominal pain or 
mesenteric adenitis 
13.13±6.22 4 - 46 
Hepatobiliary System & 
Pancreas 
malignancy of hepatobiliary system, pancreas; hepatobiliary; disorders 
of the biliary tract; 
16.93±8.62 8 - 44 
Musculoskeletal Sys & 
Conn Tissue 
sprains, strains, and dislocations of hip, pelvis, and thigh; non-surgical 
spinal disorders; injury to the shoulder, arm, elbow, knee, leg, or ankle. 
fractures of the neck of femur; distal femoral fractures; aftercare of 
musculoskeletal implants; sprains, strains, and dislocations; spinal 
fusion of hip, pelvis, and thigh; pathological fracture; musculoskeletal 
malignant neoplasms; injury to forearm, wrist, hand, or foot. 
23.01±13.64 4 - 60 
Skin, Subcutaneous 
Tissue & Breast 
trauma to the skin, subcutaneous tissue, and breast; trauma to the skin, 
subcutaneous tissue, and breast; malignant breast disorders; skin ulcers. 
19.7±9.96 
2 - 60 
3.2. Association of MDC with CHADx 
For the population of surgical patients admitted to the 
hospital, the CHADx rate of 27.68% is 10.09% higher than 
medical patients (with ELOHS rate of 17.59%) admitted in 
the same period. The P-value of the Pearson Chi-squared 
between ELOHS and NLOHS for surgical and medical 
patients having CHADx is shown in Table 3. It can be 
deduced from Table 3 that most of the MDCs have the rate 
of CHADx amongst ELOHS and NLOHS not statistically 
significant at P ≤ 0.05 because of the variation in patients' 
CHADx rates between them. Nonetheless, for medical 
patients suffering from “Nervous system” related MDC (P 
= 0.0294), and surgical patients suffering from “circulatory 
system” (P = 0.0018), “ear, nose, mouth & throat” (P = 
0.0011), and “kidney & urinary Tract” (P < 0.001) MDCs, 
there is no significant difference in the CHADx rates of the 
NLOHS and ELOHS cohorts. For surgical patients, apart 
from the “blood, blood from organs, immunology” and 
“factor influencing health status” MDCs that have 16 – 
20% more CHADx cases for ELOHS than NLOHS, other 
MDCs have more CHADx cases (7 – 1100%) amongst 
NLOHS than ELOHS patients. The same is attenable with 
medical patients that have “factor influencing health 
status” and “ear, nose, mouth &throat” MDCs that have 30 
– 105% more ELOHS cases of CHADx than those NLOHS 
patients.  Other MDCs have between 78.5 – 759% more 
cases of CHADx amongst NLOHS than ELOHS patients. 
 
Table 3: Chi-square analysis for the rate of diagnosis in patients of various age groups with Classification of Hospital-acquired Diagnosis (CHADx) 
for various MDC amongst NLOHS and ELOHS (bold means significant at 95% confidence level) 
MDC Details NLOHS (count, %) ELOHS (count, %) P value 
Medical Patients 
Blood, Blood Form Organs, Immunology 25(0.21%) 14(0.12%) 0.619 
Circulatory System 184(1.56%) 46(0.39%) 0.987 
Digestive System 118(1%) 55(0.47%) 0.09 
Ear, Nose, Mouth & Throat 23(0.19%) 30(0.25%) 0.125 
Endocrine, Nutritional & Metabolic 23(0.19%) 9(0.08%) 0.953 
Factors Influencing Health Status 18(0.15%) 37(0.31%) 0.997 
Hepatobiliary System & Pancreas 16(0.14%) 2(0.02%) 0.812 
Infectious & Parasitic Diseases 70(0.59%) 22(0.19%) 0.217 
Injury, Poison & Toxic Effect Drugs 28(0.24%) 10(0.08%) 0.920 
Kidney & Urinary Tract 82(0.69%) 25(0.21%) 0.664 
Musculoskeletal Sys & Conn Tissue 127(1.07%) 47(0.4%) 0.911 
Neoplastic Disorders 23(0.19%) 10(0.08%) 0.487 
Nervous System 110(0.93%) 55(0.47%) 0.029 
Newborns & Other Neonates 36(0.3%) 6(0.05%) 0.899 
Pregnancy, Childbirth & Puerperium 786(6.65%) - - 
Respiratory System 232(1.96%) 27(0.23%) 0.397 
Skin, Subcutaneous Tissue & Breast 39(0.33%) 12(0.1%) 0.851 
Surgical Patients 
Blood, Blood Form Organs, Immunology 12(0.05%) 14(0.06%) 0.9999 
Circulatory System 590(2.69%) 174(0.79%) 0.0018 
Digestive System 559(2.55%) 220(1%) 0.0838 
Ear, Nose, Mouth & Throat 26(0.12%) 20(0.09%) 0.0011 
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Endocrine, Nutritional & Metabolic 69(0.31%) 37(0.17%) 0.4416 
Eye Diseases & Disorders 12(0.05%) 1(0%) 0.8557 
Factors Influencing Health Status 10(0.05%) 12(0.05%) 0.6011 
Female Reproductive System 82(0.37%) 26(0.12%) 0.269 
Hepatobiliary System & Pancreas 128(0.58%) 63(0.29%) 0.2638 
Infectious & Parasitic Diseases 45(0.21%) 29(0.13%) 0.3851 
Injury, Poison & Toxic Effect Drugs 48(0.22%) 34(0.16%) 0.4959 
Kidney & Urinary Tract 134(0.61%) 82(0.37%) <0.001 
Male Reproductive System 87(0.4%) 38(0.17%) 0.2795 
Musculoskeletal Sys & Conn Tissue 608(2.77%) 210(0.96%) 0.6606 
Neoplastic Disorders 32(0.15%) 21(0.1%) 0.6105 
Nervous System 91(0.42%) 53(0.24%) 0.5148 
Pregnancy, Childbirth & Puerperium 252(1.15%) 4(0.02%) 0.0756 
Respiratory System 143(0.65%) 29(0.13%) 0.8609 
Skin, Subcutaneous Tissue & Breast 91(0.42%) 85(0.39%) 0.8113 
 
3.3 Risk Factors of ELOHS    
Some of the risk factors of ELOHS for surgical 
and medical patients at a 95% significance level (P ≤ 
0.05) are shown in Table 4. Following Table 4, the 
predictors that have the likelihood of influencing ELOHS 
for surgical patients include LOS(>20days) – (OR:4.907, 
TS (once) – (OR:2.341, ROR (Yes) – (OR: 3.05), AORT 
(60 mins) – (OR:1.807), AORT (120 mins) – (OR: 
1.622), Age (≥65) – (OR:1.794), Age (40-65) – 
(OR:1.501), HTS (4 hours) – (OR:1.621). Other 
parameters such as MDCs comprise “ear, nose, mouth & 
throat” – (OR: 7.7499), “male reproductive system” – 
(OR: 5.149), “circulatory system” – (OR: 1.995), 
“digestive system” – (OR:2.012), “factors influencing 
health status” – (OR: 2.894), etc., also influence ELOHS 
amongst surgical patients. For medical patients, the 
following parameters LOS (>20 days) – (OR:5.521), 
RRT (No calls) – (OR:4.69) and MDCs such as “ear, 
nose, mouth & throat” – (OR: 7.0513), “factors 
influencing health status” – (OR: 2.632), “neoplastic 
disorders” – (OR: 3.952) and “digestive system” – 
(OR:2.481) also have the probability of influencing 
ELOHS. Due to the smaller values of some of the other 
significant parameters (OR < 1), they may have less 
likelihood of resulting in ELOHS amongst surgical and 
medical patients.  
The accuracy of the multivariate Logistic model 
used to determine the risk factors of ELOHS is computed 
with the Receiver Operating Characteristics (ROC) Area 
Under the Curve (AUC) and confusion matrix computed 
for a 30% test data per Figure 1. The prediction accuracy 
of the surgical patients is 91.57% for training dataset and 
92.43% (AUC: 96%) for the testing dataset whereas the 
accuracy for medical patients is 94.95% for the training 
dataset and 94.36% (AUC: 97%) for the testing dataset. 
These accuracies show there is no overfitting because of 




Figure 1: Summary of Logistic model prediction accuracy of 30% 
of the data used for testing
Table 4: Significant Predictors of ELOHS with multivariate Logistic Regression analysis showing the Odds Ratio (OR), 95% 
Confidence Interval (CI), and P-Value 
Features Surgical Patients Medical Patients 
ADC(Others) OR:1.671,95% CI (1.143,2.442), P=0.008 - 
ADC(PL1) OR:0.775,95% CI (0.643,0.934), P=0.007 - 
ADC(UC1) OR:0.771,95% CI (0.642,0.927), P=0.006 - 
ADC(MAT) - OR:0.072,95% CI (0.011,0.469), P=0.006 
AORT (60 mins) OR:1.807,95% CI (1.494,2.185), P<0.001 - 
AORT (120 mins) OR:1.622,95% CI (1.339,1.965), P<0.001 - 
CHADx (Yes) OR:0.687,95% CI (0.594,0.795), P<0.001 - 
CS (>8) OR:0.173,95% CI (0.118,0.255), P<0.001 OR:0.184,95% CI (0.085,0.4), P<0.001 
CS (2-4) OR:0.454,95% CI (0.355,0.581), P<0.001 OR:0.444,95% CI (0.244,0.807), P=0.008 








CS (5-8) OR:0.297,95% CI (0.224,0.393), P<0.001 OR:0.15,95% CI (0.079,0.283), P<0.001 
DOP(Yes) OR:0.479,95% CI (0.353,0.65), P<0.001 - 
HACs (Yes) OR:0.819,95% CI (0.673,0.997), P=0.046 - 
HTS(4hrs) OR:1.621,95% CI (1.179,2.229), P=0.003 - 
ICU(Yes) OR:0.628,95% CI (0.511,0.771), P<0.001 OR:0.508,95% CI (0.267,0.965), P=0.039 
MDC   
Circulatory System OR:1.995,95% CI (1.207,3.299), P=0.007 - 
Digestive System OR:2.012,95% CI (1.245,3.25), P=0.004 OR:2.481,95% CI (1.264,4.87), P=0.008 
Ear, Nose, Mouth & Throat OR:7.75,95% CI (3.52,17.063), P<0.001 OR:7.051,95% CI (3.35,14.844), P<0.001 
Eye Diseases & Disorders OR:5.11,95% CI (1.844,14.155), P=0.002 - 
Factors Influencing Health Status OR:2.894,95% CI (1.148,7.293), P=0.024 OR:2.632,95% CI (1.231,5.629), P=0.013 
Female Reproductive System OR:9.925,95% CI (3.972,24.802), P<0.001 - 
Hepatobiliary System & Pancreas OR:2.083,95% CI (1.209,3.59), P=0.008 - 
Infectious & Parasitic Diseases OR:0.442,95% CI (0.247,0.791), P=0.006 - 
Kidney & Urinary Tract OR:2.71,95% CI (1.544,4.757), P=0.001 - 
Male Reproductive System OR:5.149,95% CI (2.545,10.414), P<0.001 - 
Skin, Subcutaneous Tissue & 
Breast OR:1.66,95% CI (1.039,2.652), P=0.034 
- 
Neoplastic Disorders - OR:3.952,95% CI (1.41,11.081), P=0.009 
Newborns & Other Neonates - OR:0.031,95% CI (0.006,0.164), P<0.001 
Respiratory System   OR:0.358,95% CI (0.181,0.708), P=0.003 
Age (40-65) OR:1.501,95% CI (1.116,2.019), P=0.007 - 
Age (≥65) OR:1.794,95% CI (1.264,2.547), P=0.001 - 
LOS(>20days) OR:4.907,95% CI (4.015,5.997), P<0.001 OR:5.521,95% CI (4.289,7.108), P <0.001 
LOS(≤5days) OR:0.002,95% CI (0.002,0.003), P<0.001 OR:0,95% CI (0,0.001), P<0.001 
LOS(6-10days) OR:0.319,95% CI (0.276,0.369), P<0.001 OR:0.039,95% CI (0.03,0.051), P <0.001 
ROR(Yes) OR:3.05,95% CI (2.209,4.211), P<0.001 - 
RRT (one call) OR:0.543,95% CI (0.44,0.67), P<0.001 OR:2.464,95% CI (1.232,4.93), P=0.011 
RRT(No)   OR:4.688,95% CI (2.581,8.516), P<0.001 
TS (once) OR:2.341,95% CI (1.857,2.953), P<0.001 - 
TS (twice) OR:0.726,95% CI (0.551,0.957), P=0.023 - 
VMO Specialty   
Cardiothoracic Surg. OR:0.182,95% CI (0.099,0.334), P<0.001 - 
Colorectal Surgery OR:0.272,95% CI (0.16,0.463), P<0.001 - 
Endocrinology OR:0.392,95% CI (0.202,0.76), P=0.006 - 
Gastroenterology OR:0.43,95% CI (0.25,0.74), P=0.002 - 
General Medicine Phy OR:0.32,95% CI (0.191,0.538), P<0.001 - 
Gerontology OR:0.265,95% CI (0.146,0.479), P<0.001 - 
Gynecology OR:0.13,95% CI (0.047,0.359), P<0.001 - 
Hematology OR:0.454,95% CI (0.247,0.834), P=0.011 - 
Medical Oncology OR:0.383,95% CI (0.219,0.67), P=0.001 - 
Neurosurgery OR:0.262,95% CI (0.143,0.481), P<0.001 - 
Obstetrics & Gynae OR:0.271,95% CI (0.089,0.824), P=0.021 - 
Orthopedic Surgery OR:0.399,95% CI (0.232,0.687), P=0.001 - 
Respiratory Medicine OR:0.405,95% CI (0.206,0.798), P=0.009 - 
Upper GI Surgery OR:0.494,95% CI (0.28,0.87), P=0.015 - 
Urogynecology OR:0.16,95% CI (0.028,0.922), P=0.04 - 
Vascular Surgery OR:0.524,95% CI (0.294,0.935), P=0.029 - 
Nephrology - OR:0.516,95% CI (0.301,0.884), P=0.016 
3.4 Association between the Risk Factors
The results of the Pearson correlation coefficient 
between the risk factors for the surgical and medical 
patients are shown in Table 5. Although the Pearson 
correlation coefficient for most of the features are 
negligible (r < ± 0.3), there are a few others that show low 
(± 0.3 < r < ± 0.5) and moderate (± 0.5 < r < ± 0.7) 
correlations. Interestingly, the features considered in this 
study have a negligible correlation with the death rate of 
surgical and medical patients, which is in contrast with 
the findings of previous studies [11]. However, Age has 
a moderate correlation with Charlson Score, LOS has a 
low correlation with CHADx, HACs, ROR, and HTS for 
surgical patients, and negligible correlation with features 
considered for medical patients except CHADx with low 
correlation. 
4.0 Discussion 
This study identifies the predictors of ELOHS for 
surgical and medical patients, shows the correlation of 
these predictors amongst each other, and establishes how 
ELOHS influences CHADx for patients with different 
MDCs. The risk of ELOHS is very predominant for 
patients who are 40 years and over and have been treated 
with MDC such as “ear, nose, mouth & throat”, “male 
reproductive system”, “circulatory system”, “digestive 
system”, “factors influencing health status” and 
Page 3668
 
“neoplastic disorders”. Previously studies have also 
linked age to ELOHS [9] because of the increased 
vulnerability of the elderly to hospital-acquired infections 
and other complications in hospitals [18]. Unfortunately, 
with these complications and ELOHS, the hospitals can 
be hit with an increased cost of managing patients and 
shortage of available bed spaces for managing new 
patients [19-20]. ELOHS is also connected to the number 
of comorbidities, health complications, and 
socioeconomic status of patients [21-22]. Nonetheless, 
despite linking ELOHS to some of the MDCs identified 
earlier, socioeconomic status did not contribute to 
ELOHS. Admission Category (ADC) played a role in 
ELOHS due to the complications faced by patients under 
certain categories and the strategies used for managing 
them. It may therefore be important to adjust caregiving 
strategies for such ADC categories in consideration of 
other risk factors to improve patients’ outcomes and 
reduce the LOS [23]. 
Even though patients that stayed > 20 days in hospital 
posed a greater risk of ELOHS, there is the need to 
balance the management of those patients staying <20 
days to forestall Hospital-acquired complications 
(HACs), which are the direct consequences of ELOHS 
[24-25]. Despite the importance of RRT calls in 
improving patients’ status on hospital admission via 
moderating pulses, respiratory rates, blood pressures, 
oxygen saturation, etc. [26-27], it provided mixed results 
for surgical and medical patients. Thus, RRT calls did not 
influence ELOHS among surgical patients but those with 
no RRT calls have 90 – 369% more risk of ELOHS 
amongst medical patients than those with one or more 
RRT calls. So, the assumption that patients who have no 
RRT calls may be doing very well and may not overstay 
their expected LOS in the hospital may not always be 
accurate. 
Table 5: Correlation matrix of the features showing Pearson Correlation coefficient r and the P-Value for the patients 
 
 
 Psychosocial factors such as DTH and SES are not 
identified risk factors of ELOHS because they are not 
significant at a 95% confidence interval, however, 
previous studies have linked the factors to ELOHS [23, 
25, 34]. Surgical patients treated for “female 
reproductive system” have between 28.06 – 497.98% 
more risk of ELOHS than patients treated for other 
MDCs. With the higher likelihood of ELOHS for “female 
reproductive system”, “ear, nose, mouth and throat”, 
“male reproductive system”, and “eye disease and 
disorder” MDC patients than the other MDCs and risk 
factors, the need for strategic plans to manage these 
patients on admission and surgical procedures cannot be 
overemphasized. Similarly, Surgical patients that spent < 
60 minutes in the operating theatre have a higher 






















































































































































































– 120 minutes in the theatre. Although it may be 
premature to make conclusions about the reasons for this 
occurrence, research has previously linked 14-17% 
hospital-acquired infections to surgical site infections 
resulting from endogenous and procedure-related risk 
factors [35]. It can also be inferred from the result that 
hospital factors such as VMO specialty e.g., hematology, 
vascular surgery, orthopedic surgery, medical oncology, 
endocrinology, neurology, colorectal surgery, 
neurosurgery, and general medical physician, have 
limited influence on ELOHS despite being risk factors. 
The risk of ELOHS amongst surgical patients also 
increased with age, a finding that is supported by 
previous studies [23, 25, 29].  
Medical patients admitted with “ear, nose, mouth and 
throat” MDC have significantly higher ELOHS 
expectation than other patients with neoplastic disorder, 
digestive system, factors influencing health, respiratory 
system and musculoskeletal system and connected 
system MDCs. Charlson score and Intensive Care Unit 
(ICU) visit though are risk factors for ELOHS have 
limited likelihood of causing ELOHS. 
 
5.0 Conclusions 
This study looked at the hospital records of 21926 
surgical and 11826 medical patients to identify the 
predictors of ELOHS using hospital and psychosocial 
factors. By using descriptive statistics, Chi-square, 
Pearson correlation, and multivariate Logistic regression, 
the risk factors of ELOHS were identified while 
establishing the prevalence of CHADx amongst ELOHS 
and NLOHS patients. It was found that 9.94% and 
12.41% of medical and surgical patients respectively 
overstayed the high trim points of their DRGs. There 
were 22 MDCs for over 90 DGRs with the high trim 
points from 3 - 60 days considered in this study. The risk 
factors of ELOHS were identified as CS, AORT, 
CHADx, HACs, DOP, HTS, ICU transfer, LOS, TS, RRT 
call, ADC, and Age. Some MDCs such as “ear, nose, 
mouth & throat”, “male reproductive system”, 
“circulatory system”, “digestive system, “factors 
influencing health status”, and “neoplastic disorders”. 
were also identified as potential risk factors of ELOHS. 
There is a difference in the prevalence of CHADx 
amongst ELOHS and NLOHS patients except for “kidney 
and urinary tract”, “nervous system”, “circulatory 
system” and “ear, nose, mouth & throat” MDCs. There is 
a moderate correlation between patients' age and the 
Charlson Score and CHADx and HACs while many other 
relationships amongst the features are low and negligible. 
It will be important to consider the risk factors in 
managing patients of different MDCs and DRG 
vulnerabilities to improve their health outcomes within 
the expected LOS. This will go a long way to reduce the 
cost of managing patients and improve their quality-of-
life.  
The limitations of this study include the reporting 
accuracy of inputted and extracted data from the database 
and the data size of some MDCs. There may be the need 
to study the MDCs separately to have a better picture of 
the predictors' behaviour. Finally, despite the DRGs 
being identified separately, it may be important to have 
better granular information about them to facilitate 
analysis that will identify predictors of ELOHS for 
different diagnosis severity.  
 
Acknowledgment  
The authors wish to thank the Digital Health Cooperative 
Research Centre (DHCRC) for the financial supports and 
other contributions that made this research possible. 
References  
[1]. S. Benenson, M.J. Cohen, C. Schwartz, M. Revva, A.E Moses,. 
and P.D. Levin, “Is it financially beneficial for hospitals to 
prevent nosocomial infections?”. BMC Health Services 
Research, 20(1), 2020, pp.1-9. 
[2]. Y. Cai, M. Zhu, W. Sun, X. Cao, and H. Wu, “Study on the cost 
attributable to central venous catheter-related bloodstream 
infection and its influencing factors in a tertiary hospital in 
China”, Health and quality of life outcomes, 2018, 16(1), pp.1-6. 
[3]. A.B. Koo, A.A. Elsamadicy, I.H. Lin, W.B. David, N. 
Sujijantarat, C. Santarosa, B.J. Cord, A. Zetchi, R. Hebert, F. 
Bahrassa, and A. Malhotra, “Predictors of Extended Length of 
Stay Following Treatment of Stay Following Treatment of 
Unruptured Adult Cerebral Aneurysms: A Study of The National 
Inpatient Sample. Journal of Stroke and Cerebrovascular 
Diseases, 29(11), p.105230. 
[4]. P.W. Stone, “Economic burden of healthcare-associated 
infections: an American perspective”, Expert review of 
pharmacoeconomics & outcomes research, 9(5), 2009, pp.417-
422. 
[5]. H.A. Khan, F.K. Baig, and R. Mehboob, “Nosocomial infections: 
Epidemiology, prevention, control and surveillance”, Asian 
Pacific Journal of Tropical Biomedicine, 7(5), 2017, pp.478-482. 
[6]. L. Deeter, M. Seaton, G.J. Carrougher, K. McMullen, S.P. 
Mandell, D. Amtmann, and N.S. Gibran, “Hospital-acquired 
complications alter quality of life in adult burn survivors: report 
from a burn model system”, Burns, 45(1), 2019, pp.42-47. 
[7]. S. Boes, and C. Napierala, “Assessment of the introduction of 
DRG-based reimbursement in Switzerland: Evidence on the 
short-term effects on length of stay compliance in university 
hospitals”, Health Policy, 2021. 
[8]. T. Jaqua, and E. Jaqua, “Factors Affecting Hospital 
Reimbursements”, J Nurs Healthcare Manage, 2, 2019, p.103. 
[9]. P.G. Passias, C.M. Jalai, N. Worley, S. Vira, S. Hasan, S.R. Horn, 
F.A. Segreto, C.A., Bortz, A.P. White, M. Gerling, and V. 
LaFage, “Predictors of hospital length of stay and 30-day 
readmission in cervical spondylotic myelopathy patients: an 
analysis of 3057 patients using the ACS-NSQIP database”, 
World neurosurgery, 110, 2018, pp.e450-e458. 
[10]. J. Deister, B.G. Cothern, C. Williams, A.W. Froehle, and R.T. 
Laughlin, “Factors predicting length of hospital stay and 
extended care facility admission after hindfoot arthrodesis 




[11]. K.J. Ho, A.L. Madenci, J.T. McPhee, M.E. Semel, R.A. 
Bafford, L. L. Nguyen, C.K. Ozaki, and M., Belkin, 
“Contemporary predictors of extended postoperative hospital 
length of stay after carotid endarterectomy”. Journal of 
vascular surgery, 59(5), 2014, pp.1282-1290. 
[12]. A. Storey, B. MacDonald, and M.A. Rahman, “The 
association between preoperative length of hospital stay and 
deep sternal wound infection: A scoping review”, Australian 
Critical Care, 2021. 
[13]. S. Tal, “Length of hospital stay among oldest-old patients in 
acute geriatric ward” Archives of Gerontology and 
Geriatrics, 94, 2021, p.104352. 
[14]. M.J. McGirt, S.L. Parker, S. Chotai, D. Pfortmiller, J.M. 
Sorenson, K. Foley, and A.L. Asher, “Predictors of extended 
length of stay, discharge to inpatient rehab, and hospital 
readmission following elective lumbar spine surgery: 
introduction of the Carolina-Semmes Grading Scale”, 
Journal of Neurosurgery: Spine, 27(4), 2017, pp.382-390. 
[15]. E.O. Klineberg, P.G. Passias, C.M. Jalai, N. Worley, D.M. 
Sciubba, , D.C. Burton, M.C. Gupta, A. Soroceanu, A., P.L. 
Zebala, G.M. Mundis Jr, and H.J. Kim, “Predicting extended 
length of hospital stay in an adult spinal deformity surgical 
population”, Spine, 41(13), 2016, pp.E798-E805. 
[16]. T.L. Flanigan, E.M. Kiskaddon, J.A. Rogozinski, M.D. 
Thomas, A.W. Froehle, and A.B. Krishnamurthy, 
“Predictive Factors of Extended Length of Hospital Stay 
Following Total Joint Arthroplasty in a Veterans Affairs 
Hospital Population”, The Journal of Arthroplasty, 36(5), 
2021, pp.1527-1532. 
[17]. ABS (Australian Bureau of Statistics), An introduction to 
socio-economic indexes for areas (SEIFA), Commonwealth 
of Australia, ABS, Canberra, 2011. Available from 
https://www.abs.gov.au/websitedbs/censushome.nsf/home/s
eifa 26/05/2021 
[18]. M. Avci, O. Ozgenc, S.A. Coskuner, and A.I. Olut, “Hospital 
acquired infections (HAI) in the elderly: comparison with the 
younger patients”, Archives of gerontology and geriatrics, 
54(1), 2012, pp.247-250. 
[19]. H.J. Toh, Z.Y. Lim, P. Yap, and T. Tang, “Factors associated 
with prolonged length of stay in older patients”, Singapore 
medical journal, 58(3), 2017, p.134. 
[20]. P. Hendy, J.H. Patel, T. Kordbacheh, N. Laskar, and M. 
Harbord, “In-depth analysis of delays to patient discharge: a 
metropolitan teaching hospital experience”, Clinical 
Medicine, 12(4), 2012, p.320. 
[21]. M. Bo, G. Fonte, F. Pivaro, M. Bonetto, C. Comi, V. Giorgis, 
L. Marchese, G. Isaia, G. Maggiani, E. Furno, and Y. 
Falcone, "Prevalence of and factors associated with 
prolonged length of stay in older hospitalized medical 
patients”, Geriatrics & gerontology international, 16(3), 
2016, pp.314-321. 
[22]. B.A. Marfil-Garza, P.F. Belaunzarán-Zamudio, A. Gulias-
Herrero, A.C. Zuñiga, Y. Caro-Vega, D. Kershenobich-
Stalnikowitz, and J. Sifuentes-Osornio, “Risk factors 
associated with prolonged hospital length-of-stay: 18-year 
retrospective study of hospitalizations in a tertiary healthcare 
center in Mexico”, PloS one, 13(11), 2018, p.e0207203. 
[23]. M.E. Anderson, J.J. Glasheen, D. Anoff, R. Pierce, R. Capp, 
and C.D. Jones, “Understanding predictors of prolonged 
hospitalizations among general medicine patients: A guide 
and preliminary analysis”, Journal of hospital medicine, 
10(9), 2015, pp.623-626. 
[24]. S.P. Kim, N.D. Shah, R.J. Karnes, C.J. Weight, I. Frank, J.P. 
Moriarty, L.C. Han, B. Borah, M.K. Tollefson, and S.A. 
Boorjian, “The implications of hospital acquired adverse 
events on mortality, length of stay and costs for patients 
undergoing radical cystectomy for bladder cancer”, The 
Journal of urology, 187(6), 2012, pp.2011-2017. 
[25]. N. Kumar, R.S. Patel, S.S.Y. Wang, J.Y.H. Tan, A. Singla, 
Z. Chen, N. Ravikumar, A. Tan, N. Kumar, D.H.W. Hey, and 
S.V. Prasad, “Factors influencing extended hospital stay in 
patients undergoing metastatic spine tumour surgery and its 
impact on survival”, Journal of Clinical Neuroscience, 56, 
2018, pp.114-120. 
[26]. C.L. Downey, W. Tahir, R. Randell, J.M. Brown, and D.G. 
Jayne, “Strengths and limitations of early warning scores: a 
systematic review and narrative synthesis”, International 
Journal of Nursing Studies, 76, 2017, pp.106-119. 
[27]. S. Crouch, L.G. Trahair, and L.M. Aitken, “The use of 
altered rapid response calling criteria in a tertiary referral 
facility”, Australian Critical Care, 34(3), 2021, pp.204-208. 
[28]. R.W. Krell, M.E. Girotti, and J.B. Dimick, “Extended length 
of stay after surgery: complications, inefficient practice, or 
sick patients?”, JAMA surgery, 149(8), 2014, pp.815-820. 
[29]. Australian Institute of Health and Welfare, Health 
expenditure Australia 2018–19. Health and Welfare 
expenditure series no.66. Cat. no. HWE 80. Canberra: 




[30]. B.L. Dial, V.R. Esposito,.R. Danilkowicz, J. O’Donnell, B. 
Sugarman, D.J. Blizzard and M. E. Erickson,  “Factors 
associated with extended length of stay and 90-day 
readmission rates following ACDF”. Global spine journal, 
10(3), 2020, pp.252-260. 
[31]. A. A. Elsamadicy, A.B. Koo, A.J. Kundishora, F. Chouairi, 
M. Lee, A.C. Hengartner, J. Camara-Quintana, K. T. Kahle, 
and M. L. DiLuna.  “Impact of patient and hospital-level risk 
factors on extended length of stay following spinal fusion for 
adolescent idiopathic scoliosis”. Journal of Neurosurgery: 
Pediatrics, 24(4), 2019, pp.469-475. 
[32]. K.M. Trentino, S. G. Swain, S.A. Burrows, P. C. Sprivulis 
and F. F. Daly, “Measuring the incidence of hospital‐
acquired complications and their effect on length of stay 
using CHADx”. Medical Journal of Australia, 199(8), 2013, 
pp.543-547. 
[33]. Australian Commission on Safety and Quality in Healthcare 
(ACSQH), Classification of Hospital Acquired Diagnoses, 
available from < https://www.safetyandquality.gov.au/our-
work/indicators/classification-of-hospital-acquired-
diagnoses> 23/08/2021 
[34]. A. K. Ghosh, B. P. Geisler and S. Ibrahim, S., “Racial/ethnic 
and socioeconomic variations in hospital length of stay: A 
state-based analysis. Medicine, 100(20), 2021. 
[35]. A. M. Spagnolo, G. Ottria, D. Amicizia, F. Perdelli and M. 
L. Cristina, “Operating theatre quality and prevention of 
surgical site infections”. Journal of preventive medicine and 
hygiene, 54(3), 2013, p.131. 
 
Page 3671
